Could GLP-1 weight-loss drugs boost survival for colon cancer patients?
Colon cancer patients taking GLP-1 medications were less than half as likely to die within five years compared to those who weren’t on the drugs. – Image credit UC San Diego Today CANCER DIGEST – Nov. 15, 2025 – An analysis of data from nearly 7,000 colon cancer patients treated at cancer centers throughout California showed that patients who were taking a class of drug called glucagon-like peptide-1 (GLP-1) were more likely to survive compared to similar patients who were no
Young adults with rectal bleeding linked to 8.5 times higher risk of colorectal cancer
Patients under age 50 who undergo colonoscopy to investigate rectal bleeding have been found to have eight times the risk of colorectal cancer
Novel 'off-the-shelf' vaccine shows promise against deadly pancreatic and colorectal cancers
A novel cancer vaccine designed to rally the body's immune system against a common cancer-driving gene mutation.
Cancer linked to obesity tripled in the U.S. over past 20 years
Deaths from obesity-linked cancers have tripled in two decades – Photo credit Unsplash Media CANCER DIGEST – July 20, 2025 – Cancers...
Permanent gene editing of T cell DNA shown to be safe in first clinical trial
New gene-editing therapy shows early success in fighting advanced GI cancers. Illustration provided by University of Minnesota
Opdivo approved for subtype of colorectal cancer
From 5% to 15% of people colorectal cancer have the MSI-H subtype CANCER DIGEST – April 12, 2025 – The FDA this week approved another...
